Over 20 years

of laboratory research experience

International expertise in scientific management.
Highly qualified research team.

Research

and development.

We develop innovative drugs,
experimental methodologies and clinical techniques.

Innovation

Proprietary experimental protocols
to move beyond current boundaries
of biomedical research.

Development of new drugs for personalized treatment of chronic,
inflammatory and degenerative diseases.

Design of innovative small molecules.

Proprietary Research

Our Pipeline

Our Pipeline

Flav-X Platform

Flav-X Platform

Our Library

Our Library

Custom-made Drugs & Platforms

Custom-made Drugs & Platforms

Our Services

BASIC RESEARCH

Gene expression
Immunoassay
Epithelial Barrier
Proteomic
Signal Transduction
Cell Death & Apoptosis
Cell Migration
Cell Invasion
Cell Proliferation
Cell Adhesion

DRUG DISCOVERY

Drug Synthesis
Cytotoxicity Assays
Efficacy & Side Effects
Lead Compound Screening
Target Identification
Mechanisms of Action

PRECLINICAL RESEARCH

PoC1 Studies
Toxicology Studies
Animal Models of Disease
PK & PD2 Testing
Animal Imaging

Do you want to help?

Support Research! Find out how …

News

Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

7 December 20207 December 2020

Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.

Vera Salus Ricerca Srl, in collaboration with the Sicilian Zooprophylactic Institute and the National Reference Center for Toxoplasmosis, just published a research study in the Journal of Food Protection concerning the safety of novel foods with respect to Toxoplasma gondii infections. The paper, entitled “Edible insects and Toxoplasma gondii: is it something we need to be concerned about?”, provides evidences of the risk for public health poised by Toxoplasma gondii entering the human food chain through contaminated novel edible foods and causing toxoplasmosis disease in exposed individuals

2 November 20202 November 2020

Vera Salus Ricerca Srl, in collaboration with the Sicilian Zooprophylactic Institute and the National Reference Center for Toxoplasmosis, just published a research study in the Journal of Food Protection concerning the safety of novel foods with respect to Toxoplasma gondii infections. The paper, entitled “Edible insects and Toxoplasma gondii: is it something we need to be concerned about?”, provides evidences of the risk for public health poised by Toxoplasma gondii entering the human food chain through contaminated novel edible foods and causing toxoplasmosis disease in exposed individuals